세계의 수액 약국 관리 시장 : 제품 유형별, 용도별, 질환별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Infusion Pharmacy Management Market, By Product Type, By Application, By Diseases, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,539,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,495,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,892,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

수액 약국 관리(Infusion Pharmacy Management) 시장 규모는 2022년 417억 260만 달러였으며, 2023년부터 2030년까지 CAGR 7.4%로 추이하며 성장할 것으로 예상됩니다.

수액 약국 관리 시장 - 시장 역학 :

• 재택치료 서비스의 동향이 시장 성장을 견인
• 병원 기반 클리닉은 비용 및 환자 불편과 관련된 단점이 있기 때문에 가장 비용이 많이 드는 수액 치료 옵션입니다. 또한 클리닉이 특정 시간에만 운영되는 경우 환자는 예약을 위해 더 오래 기다려야 합니다. 반면에 독립형 수액 클리닉은 병원 기반 클리닉에 비해 지역 사회 주변에 위치하며 가격이 저렴하기 때문에 더 실용적일 수 있습니다. 이러한 대체 장소가 환자의 주 종양학 팀에 속하지 않는 경우, 서로 다른 치료 팀 간의 의사소통이 원활하지 않아 치료가 파편화될 수 있습니다. 이에 따라 가격은 독립형 수액 클리닉과 비슷해 보이지만 재택 수액은 병원 기반 클리닉보다 비용이 훨씬 저렴합니다. 이 방법은 환자가 집에서 수액을 맞을 수 있도록 도와주기 때문에 이동이 필요한 독립형 수액 클리닉에 더 적합합니다. 결과적으로 위에서 언급 한 요인은 글로벌 수액 약국 관리 시장의 성장을 촉진 할 것으로 예상됩니다. 그러나 숙련 된 전문가의 부족과 높은 비용은 시장 성장을 저해 할 것으로 예상됩니다.

수액 약국 관리 시장-세분화 분석 :

• 세계의 수액 약국 관리 시장은 제품 유형, 용도, 질환, 지역에 따라 구분됩니다.
• 제품 유형에 따라 항균, 통증 관리, 체내 영양, 항생제 등 4가지로 분류됩니다. 통증 관리 분야는 급속한 성장을 목격하고 있습니다. 이는 대상 포진 후 신경통, 당뇨병 성 신경 병증, 섬유 근육 통증, 환지 통증, 당뇨병 성 신경 병증, 신경 병성 통증, 뇌졸중 및 척수와 관련된 중추성 통증과 같은 여러 통증 증후군을 치료합니다. 때문입니다. 또한 항생제 분야가 가장 높은 수익 점유율을 차지할 것으로 예상됩니다. 항생제는 동물과 인간의 박테리아 감염을 치료하는 데 사용되는 약물입니다. 항생제는 박테리아를 제거하거나 박테리아의 발달과 번식을 어렵게 함으로써 이것을 실현합니다.
• 시장은 용도에 따라 외래수술센터, 재택의료, 병원 및 클리닉의 3가지로 분류됩니다. 병원 및 클리닉 부문은 예측 기간 동안에도 우위성을 유지할 것 같습니다. 이 분야 수요는 다양한 질환을 가진 환자 증가로 인한 것입니다. 재택 관리 분야는 재택 수액 요법의 이점으로 인해 가장 높은 성장률이 예상됩니다. 이 서비스는 환자가 가장 편안하게 느끼는 환경에서 치료를 받을 수있는 기회를 제공합니다.

수액 약국 관리 시장-지리적 통찰

수액 약국 관리 시장은 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카에 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가별로 더욱 세분화됩니다. 예측 기간 동안 북미는 시장을 독점할 것으로 보입니다. 이 지역의 확대는 노인 인구 증가와 만성 질환 환자 증가로 인한 것입니다. 게다가 아시아 태평양시장은 인도와 중국 등 신흥국에서 최첨단 건강관리시설의 이용 확대로 크게 상승할 가능성이 높습니다. 또한, 수액 치료의 이점에 대한 사회적인지도 증가와 대규모 환자 인구의 존재가 시장의 수익 성장을 가속할 것으로 예상됩니다.

수액 약국 관리 시장-경쟁 구도 :

수액 치료는 경구 약물보다 효율적이므로 시장 성장을 뒷받침합니다. 또한 주요 의료 기술 기업이 중소기업을 인수함에 따라 시장은 솔루션 포트폴리오를 확대하기 위해 통합되고 있습니다. 이 통합의 결과로 엔드 투 엔드 수액 약국 관리 기능을 제공하는 종합적인 플랫폼이 개발되었습니다. 또한 시장 진출 기업은 연구개발 활동, 제휴, 협업 등 다양한 전략을 내세우고 있습니다. 예를 들어, 세계 건강 관리 기업인 AmerisourceBergen은 2022년 4월 병원 및 의료 시스템의 재택 수액 서비스 라인을 시작하고 최적화하는 데 도움이 되는 프로그램을 발표했습니다. 또한, 현장 관리 전략의 중요성이 높아짐에 따라 외래 수액 센터의 실적이 호조를 보이는 의료 시스템은 잠재적인 관리 격차를 방지하기 위해 재택 수액을 점점 더 활용하고 있습니다.

목차

제1장 수액 약국 관리 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 수액 약국 관리-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 수액 약국 관리-산업 연구 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 수액 약국 관리 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 수액 약국 관리 시장 상황

• 수액 약국 관리 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 수액 약국 관리 시장-제품 유형별

• 개요
  • 제품 유형별 부문 점유율 분석
  • 항균
  • 통증 관리
  • 체내 영양
  • 항생제
  • 기타

제8장 수액 약국 관리 시장-용도별

• 개요
  • 용도별 부문 점유율 분석
  • 외래수술센터(ASC)
  • 재택의료
  • 병원 및 클리닉

제9장 수액 약국 관리 시장-질환별

• 개요
  • 질환별 부문 점유율 분석
  • 암
  • 통증 관련 질환
  • 당뇨병
  • 기타

제10장 수액 약국 관리 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석-수액 약국 관리 산업

• 경쟁 대시보드
• 기업 개요
  • PharMerica Corporation
  • Sentara Healthcare
  • Magellan Rx Management LLC
  • CARECENTA INC.
  • Brightree
  • SSRx
  • CVS Health
  • MCKESSON CORPORATION
  • ContinuumRx
  • Prochant LLC
  • CarepathRx
  • Providence
  • Inovalon
  • Cigna
  • Centene Corporation
  • OSF Healthcare System
  • Norton Healthcare

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Infusion pharmacy management market size was valued at USD 41,702.6 Million in 2022, expanding at a CAGR of 7.4% from 2023 to 2030.

Medications or drugs are administered during infusion treatment by a sterilized catheter or needle. A professional healthcare provider secures them and regularly inserts them in the patient's vein. Additionally, only patients whose health has not yet improved and who do not react to oral treatment are often recommended this therapy Moreover, at the infusion pharmacy antiviral, antibiotics, antifungals, pain management medications, and nutritional pharmaceuticals are infused into the patient's body via a catheter or needle. The infusion medicine system is utilized to treat several diseases, such as diabetes, cancer, gastrointestinal disorders, and illnesses related to pain.

Infusion Pharmacy Management Market - Market Dynamics:

• The rise in the trend of homecare services drives the market growth

• Hospital-based clinics are the most costly option for infusion, as these drawbacks are related to expense and patient discomfort. In addition, patients would have to wait longer for appointments if a clinic only operates within certain hours. On the other side, freestanding infusion clinics may be more practical as compared to hospital-based clinics, as their given place around the community and less expensive prices. If these alternate places do not belong to the patient's primary oncology team, treatment may be fragmented because of poor communication between the different care teams. In line with this, even though the pricing seems comparable to that of freestanding infusion clinics, home infusion s considerably less costly than hospital-based clinics. This method is superior for standalone infusion clinics that need transportation simply because it helps patients to receive infusions at home. As a result, above mention factors are projected to boost the growth of the global infusion pharmacy management market. However, the lack of skilled professionals and high costs are expected to hinder market growth.

Infusion Pharmacy Management Market - Key Insights:

• As per the analysis shared by our research analyst, the global infusion pharmacy management market is estimated to grow annually at a CAGR of around 7.4% over the forecast period (2023-2030)

• The infusion pharmacy management industry is projected to grow at a significant rate due to the growing awareness home care services

• Based on product type segmentation, pain management was predicted to show maximum market share in the year 2022

• The rising prevalence of chronic diseases including diabetes, pain-related diseases, gastrointestinal disorders, and cancer is the primary factor fueling the market growth

• Pharmaceutical companies taken numerous initiatives to develop the healthcare infrastructure and make technological advancements that will drive the market growth

Infusion Pharmacy Management Market- Segmentation Analysis:

• The global infusion pharmacy management market is segmented on the basis of product type, application, diseases, and region.

• The market is divided into four categories based on product type: antimicrobial, pain management, internal nutrition, antibiotics, and others. The pain management segment is accounted witnessed speedy growth. This is attributed to treating several pain syndromes, including post-herpetic neuralgia, diabetic neuropathy, fibromyalgia, phantom limb pain, diabetic neuropathy, neuropathic pain, and central pain related to stroke or spinal cord. Moreover, the antibiotics segment is projected to hold the highest revenue share. Antibiotics are medicine used for treating bacterial infections in both animals and humans. They achieve this by removing the bacteria or making it tougher for them to develop and reproduce.

• The market is divided into three categories based on application: ambulatory surgical centers, homecare, and hospital & clinic. The hospital & clinic segment is likely to maintain its dominance during the forecast period. The segment demand is attributable to the increasing cases of patients with various diseases. The homecare segment is expected to experience the highest growth rate, due to the benefits of home infusion therapy. This service offers patients the opportunity to receive therapy in the setting in which they feel most comfortable.

Infusion Pharmacy Management Market- Geographical Insights

Geographically, the infusion pharmacy management market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is accounted to dominate the market during the forecast period. The expansion in the region is attributed to the rising geriatric population and the increasing cases of chronic disease. Moreover, the Asia-Pacific market is likely to rise significantly due to the expanding usage of cutting-edge healthcare facilities in emerging nations such as India and China. In addition, it is expected that the growing public awareness of the benefits of infusion treatment and the presence of a sizeable patient population will fuel the market revenue growth.

Infusion Pharmacy Management Market- Competitive Landscape:

Infusion medication is more appropriate than oral medication, since it is more efficient, propelling the market growth. Moreover, as larger healthcare technology companies acquire smaller players the market is witnessing consolidation to expand their portfolio of solutions. As a result, of this integration, comprehensive platforms that offer end-to-end infusion pharmacy management capabilities have been developed. Furthermore, market players are including various strategies such as R&D activities, partnerships, and collaboration. For instance, in April 2022, AmerisourceBergen a global healthcare company announced a program to assist hospitals and health systems launch or optimizing home infusion service lines. Moreover, as site-of-care strategies grow in importance, health systems with strong outpatient infusion center performance are increasingly leveraging home infusion to prevent potential care gaps, especially as therapeutic advancements continue to increase the range of home treatments available.

Recent Developments:

For instance, in September 2021, B. Braun Medical Inc launched its new CARESAFE™ IV Administration Sets with an Optional AirStop component. Additionally, they offer an added level of protection for the environment and, most essentially, to patients from the potential health risks associated with exposure to these chemicals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET KEY PLAYERS

• PharMerica Corporation
• Sentara Healthcare
• Magellan Rx Management LLC
• CARECENTA INC.
• Brightree
• SSRx
• CVS Health
• MCKESSON CORPORATION
• ContinuumRx
• Prochant LLC
• CarepathRx
• Providence
• Inovalon
• Cigna
• Centene Corporation
• OSF Healthcare System
• Norton Healthcare

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY PRODUCT TYPE

• Antimicrobial
• Pain Management
• Internal Nutrition
• Antibiotics
• Others

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY APPLICATION

• Ambulatory Surgical Centers
• Homecare
• Hospital & Clinic

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY DISEASES

• Cancer
• Pain Related Diseases
• Diabetes
• Others

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY REGION

• North America
• The U.S.
• Canada

• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC

• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Infusion Pharmacy Management Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Infusion Pharmacy Management Market Snippet by Product Type
  • 2.1.2. Infusion Pharmacy Management Market Snippet by Application
  • 2.1.3. Infusion Pharmacy Management Market Snippet by Diseases
  • 2.1.4. Infusion Pharmacy Management Market Snippet by Country
  • 2.1.5. Infusion Pharmacy Management Market Snippet by Region
• 2.2. Competitive Insights

3. Infusion Pharmacy Management Key Market Trends

• 3.1. Infusion Pharmacy Management Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Infusion Pharmacy Management Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Infusion Pharmacy Management Market Opportunities
• 3.4. Infusion Pharmacy Management Market Future Trends

4. Infusion Pharmacy Management Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Infusion Pharmacy Management Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Infusion Pharmacy Management Market Landscape

• 6.1. Infusion Pharmacy Management Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Infusion Pharmacy Management Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
  • 7.1.2. Antimicrobial
  • 7.1.3. Pain Management
  • 7.1.4. Internal Nutrition
  • 7.1.5. Antibiotics
  • 7.1.6. Others

8. Infusion Pharmacy Management Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
  • 8.1.2. Ambulatory Surgical Centers
  • 8.1.3. Homecare
  • 8.1.4. Hospital & Clinic

9. Infusion Pharmacy Management Market - By Diseases

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Diseases, 2022&2030 (%)
  • 9.1.2. Cancer
  • 9.1.3. Pain Related Diseases
  • 9.1.4. Diabetes
  • 9.1.5. Others

10. Infusion Pharmacy Management Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Infusion Pharmacy Management Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Infusion Pharmacy Management Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Infusion Pharmacy Management Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Infusion Pharmacy Management Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Infusion Pharmacy Management Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Infusion Pharmacy Management Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. PharMerica Corporation
  • 11.2.2. Sentara Healthcare
  • 11.2.3. Magellan Rx Management LLC
  • 11.2.4. CARECENTA INC.
  • 11.2.5. Brightree
  • 11.2.6. SSRx
  • 11.2.7. CVS Health
  • 11.2.8. MCKESSON CORPORATION
  • 11.2.9. ContinuumRx
  • 11.2.10. Prochant LLC
  • 11.2.11. CarepathRx
  • 11.2.12. Providence
  • 11.2.13. Inovalon
  • 11.2.14. Cigna
  • 11.2.15. Centene Corporation
  • 11.2.16. OSF Healthcare System
  • 11.2.17. Norton Healthcare

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us